SOLARIS PHARMA CORP FDA Approval ANDA 212845

ANDA 212845

SOLARIS PHARMA CORP

FDA Drug Application

Application #212845

Application Sponsors

ANDA 212845SOLARIS PHARMA CORP

Marketing Status

Prescription001

Application Products

001GEL;TOPICAL1.2%;0.025%0CLINDAMYCIN PHOSPHATE AND TRETINOINCLINDAMYCIN PHOSPHATE; TRETINOIN

FDA Submissions

UNKNOWN; ORIG1AP2022-02-10STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB2

CDER Filings

SOLARIS PHARMA CORP
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212845
            [companyName] => SOLARIS PHARMA CORP
            [docInserts] => ["",""]
            [products] => [{"drugName":"CLINDAMYCIN PHOSPHATE AND TRETINOIN","activeIngredients":"CLINDAMYCIN PHOSPHATE; TRETINOIN","strength":"1.2%;0.025%","dosageForm":"GEL;TOPICAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"02\/10\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-02-10
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.